You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 5, November 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Liothyronine Treatment in Psychotic and Nonpsychotic Children Under 6 Years

Magda Campbell, MD; Barbara Fish, MD; Raphael David, MD; Theodore Shapiro, MD; Patrick Collins, PhD; Celedonia Koh, MD

Arch Gen Psychiatry. 1973;29(5):602-608.


Abstract

Liothyronine sodium (Cytomel) was administered to 14 psychotic and six severely disturbed nonpsychotic euthyroid preschool-age children over a period of 11 to 19 weeks.

This controlled study explored the effects of liothyronine: it was found to be physiologically active and, as demonstrated by statistical analysis of ratings, is an effective therapeutic agent in both groups of children regardless of the level of motor activity. It had antipsychotic as well as stimulating properties.

All but six patients received short-term trials of dextroamphetamine sulfate (Dexedrine) to compare the effects of the two drugs. Dextroamphetamine was equally ineffective in hyper- and hypoactive psychotic patients. The behavioral and physiological effects of liothyronine in these "euthyroid" psychiatric patients are discussed, as well as its mechanism of action in psychotic children and adults in terms of possible thyroid dysfunction.



Author Affiliations

New York

From the departments of psychiatry (Drs. Campbell, Fish, Shapiro, Collins, and Koh) and pediatrics (Dr. David), New York University Medical Center, New York. Dr. Fish is currently with the Department of Psychiatry, University of California, Los Angeles.


Footnotes

Accepted for publication April 30, 1973.

Read in part before the annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, Dec 15, 1972.

Reprint requests to the Children's Hospital Psychopharmacology Unit, New York University Medical Center, 550 First Ave, New York 10016 (Dr. Campbell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Medication effects in handicapped preschool children
Simeonsson and Simeonsson
Topics in Early Childhood Special Education 1981;1:61-75.
 

Biogenic Amines in Autistic and Atypical Children: Cerebrospinal Fluid Measures of Homovanillic Acid and 5-Hydroxyindoleacetic Acid
Cohen et al.
Arch Gen Psychiatry 1974;31:845-853.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.